Status:

COMPLETED

Effect of Remimazolam and Sevoflurane Anesthesia on Recovery in Pediatric Patients

Lead Sponsor:

Pusan National University Yangsan Hospital

Conditions:

Ophthalmic Abnormalities

Pediatric Disorder

Eligibility:

All Genders

3-18 years

Brief Summary

The most commonly used anesthetic for general anesthesia in pediatric patients is sevoflurane, an inhalation anesthetic. However, the incidence of emergence agitation after sevoflurane anesthesia in p...

Detailed Description

* The most commonly used anesthetic for general anesthesia in pediatric patients is sevoflurane, an inhalation anesthetic. It has the advantage of being able to induce anesthesia without securing an i...

Eligibility Criteria

Inclusion

  • Patients aged between 3 and 18 years old who underwent ophthalmic surgery under general anesthesia
  • When anesthesia was induced and maintained with remimazolam, or anesthesia was induced with propofol and maintained with sevoflurane.

Exclusion

  • \- none

Key Trial Info

Start Date :

July 31 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 31 2024

Estimated Enrollment :

146 Patients enrolled

Trial Details

Trial ID

NCT06053489

Start Date

July 31 2023

End Date

August 31 2024

Last Update

November 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pusan National University Yangsan Hospital

Yangsan, South Korea